Fuan Pharmaceutical Group Chongqing Libang Pharmaceutical Development Co., Ltd.

Fuan Pharmaceutical Group Chongqing Libang Pharmaceutical Development Co., Ltd. (referred to as "Libang Pharmaceutical") is a wholly-owned subsidiary of Fuan Pharmaceutical (Group) Joint-stock Co., Ltd. It is located at the foot of Zhaomu Mountain in the High-tech Park of Chongqing Northern New District, and is a modern high-tech enterprise specializing in new drug research. Libang Pharmaceutical has a comprehensive pharmaceutical R&D discipline setup, with technology leaders and expert management teams possessing high technical levels and rich practical experience in pharmaceutical chemistry, pharmaceutics, pharmaceutical analysis, pharmacology and other professional fields. It currently has more than 80 employees, over 30% of whom hold master's degrees or above. Their professional fields cover medicinal chemistry, pharmaceutical analysis, pharmaceutics, pharmacology, medicine and other disciplines, with an average age of 30. The company has departments including the Synthesis Department, Formulation Department, Analysis Department, Research Management Department, and Development Department, fully responsible for the Group's project initiation and topic selection, synthesis process research of new drugs and key intermediates, formulation research, establishment of quality standard systems, registration applications, intellectual property management, and science and technology project applications. Since its founding in 2008, Libang Pharmaceutical has registered more than 100 research projects. As the standing council member unit of the Chongqing New Drug Creation Industry Technology Innovation Strategic Alliance and one of the main member units of the * Innovative Drug Incubation Base, it has undertaken multiple major new drug creation projects under the "Eleventh Five-Year Plan" and "Twelfth Five-Year Plan", National Innovation Fund projects, and municipal-level technical research projects. Its research direction and focus are concentrated on major disease treatment areas such as infection, tumors, digestive system, mental and nervous system, cardiovascular and cerebrovascular systems, as well as the development of new technologies and new products for novel characteristic drug delivery systems. It is committed to building a professional, high-quality, and standardized pharmaceutical product and technology development base for Fuan Pharmaceutical Group, and aspires to become a "*, internationally renowned" modern R&D enterprise.